The Treatment of PD-1 Antibody Combined With Peg-IFNα in NAs-suppressed CHB Patients
Clinical trial NCT06357806 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06357806
- Sponsor
- Beijing 302 Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-17
- Primary completion
- 2026-10-08
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.